Market Overview

UPDATE: Stifel Nicolaus Initiates Henry Schein at Hold on Valuation

Share:
Related HSIC
Atossa Genetics Soars On Distribution Pact With Henry Schein
Top 4 Stocks In The Medical Equipment Wholesale Industry With The Highest EPS Growth Forecast For Next Year
The Best Stocks To Buy This Week (Seeking Alpha)

Stifel Nicolaus initiated coverage on Henry Schein (NASDAQ: HSIC) with a Hold rating.

Stifel Nicolaus commented, "Henry Schein's market share gains in N.A. dental and veterinary have outpaced that of Patterson, the company's biggest competitor. As a result, we believe Schein's premium valuation is well deserved. That said, for the stock to post 20% upside from current levels, Henry Schein would need to recapture a 20x NTM EPS multiple. The stock's peak multiple over the past three years is in the high teens."

Henry Schein closed at $82.23 on Wednesday.

Latest Ratings for HSIC

DateFirmActionFromTo
Nov 2014Credit SuisseMaintainsNeutral
Nov 2014JP MorganMaintainsNeutral
Nov 2014Credit SuisseMaintainsNeutral

View More Analyst Ratings for HSIC
View the Latest Analyst Ratings

Posted-In: Stifel NicolausAnalyst Color Initiation Intraday Update Analyst Ratings

 

Related Articles (HSIC)

Around the Web, We're Loving...